Literature DB >> 23589176

Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions.

Gautier Chene1, Andrei Tchirkov, Eleonore Pierre-Eymard, Jacques Dauplat, Ines Raoelfils, Anne Cayre, Emmanuel Watkin, Philippe Vago, Frederique Penault-Llorca.   

Abstract

PURPOSE: Genetic instability plays an important role in ovarian carcinogenesis. We investigated the level of telomere shortening and genomic instability in early and preinvasive stages of ovarian cancer, serous tubal intraepithelial carcinoma (STIC), and tubo-ovarian dysplasia (TOD). EXPERIMENTAL
DESIGN: Fifty-one TOD from prophylactic salpingo-oophorectomies with BRCA1 or 2 mutation, 12 STICs, 53 tubo-ovarian high-grade serous carcinoma, and 36 noncancerous controls were laser capture microdissected from formalin-fixed, paraffin-embedded sections, analyzed by comparative genomic hybridization (array CGH) and for telomere length (using quantitative real-time PCR based on the Cawthon's method). TOD and STICs were defined by morphologic scores and immunohistochemical expressions of p53, Ki67, and γH2AX.
RESULTS: TOD showed marked telomere shortening compared with noncancerous controls (P < 10(-7)). STICs had even shorter telomeres than TOD (P = 0.0008). Ovarian carcinoma had shorter telomeres than controls but longer than STICs and dysplasia. In TOD, telomeres were significantly shorter in those with BRCA1 mutation than in those with BRCA2 mutation (P = 0.005). In addition, γH2AX expression in TOD and STIC groups with short telomeres was significantly increased (P < 10(-7)). In dysplastic epithelium, we found subtle genomic alterations, in contrast to more important genomic imbalances in STICs. The total number of genetic alterations was the highest in ovarian cancers.
CONCLUSIONS: These findings suggest that genetic instability occurs in early stages of ovarian tumorigenesis. STICs and noninvasive dysplasia are likely an important step in early serous ovarian neoplasia. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589176     DOI: 10.1158/1078-0432.CCR-12-3947

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  Telomere length and mortality following a diagnosis of ovarian cancer.

Authors:  Joanne Kotsopoulos; Jennifer Prescott; Immaculata De Vivo; Isabel Fan; John Mclaughlin; Barry Rosen; Harvey Risch; Ping Sun; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-26       Impact factor: 4.254

2.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Authors:  Ruth Perets; Gregory A Wyant; Katherine W Muto; Jonathan G Bijron; Barish B Poole; Kenneth T Chin; Jin Yun H Chen; Anders W Ohman; Corey D Stepule; Soongu Kwak; Alison M Karst; Michelle S Hirsch; Sunita R Setlur; Christopher P Crum; Daniela M Dinulescu; Ronny Drapkin
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

Review 3.  Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Authors:  Mark E Sherman; Ronny I Drapkin; Neil S Horowitz; Christopher P Crum; Sue Friedman; Janice S Kwon; Douglas A Levine; Ie-Ming Shih; Donna Shoupe; Elizabeth M Swisher; Joan Walker; Britton Trabert; Mark H Greene; Goli Samimi; Sarah M Temkin; Lori M Minasian
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-24

4.  Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.

Authors:  Shiho Asaka; Christine Davis; Shiou-Fu Lin; Tian-Li Wang; Christopher M Heaphy; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

5.  KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.

Authors:  Stina M Singel; Crystal Cornelius; Elma Zaganjor; Kimberly Batten; Venetia R Sarode; Dennis L Buckley; Yan Peng; George B John; Hsiao C Li; Navid Sadeghi; Woodring E Wright; Lawrence Lum; Timothy W Corson; Jerry W Shay
Journal:  Neoplasia       Date:  2014-03       Impact factor: 5.715

6.  Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.

Authors:  Meng Yang; Jennifer Prescott; Elizabeth M Poole; Megan S Rice; Laura D Kubzansky; Annika Idahl; Eva Lundin; Immaculata De Vivo; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-16       Impact factor: 4.254

7.  Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.

Authors:  Elizabeth Morency; Mario M Leitao; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2016-05       Impact factor: 2.762

8.  Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma.

Authors:  G Chene; V Ouellet; K Rahimi; V Barres; L Meunier; M De Ladurantaye; D Provencher; A M Mes-Masson
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 9.  Early preinvasive lesions in ovarian cancer.

Authors:  Gautier Chene; Gery Lamblin; Karine Le Bail-Carval; Philippe Chabert; Naoual Bakrin; Georges Mellier
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

Review 10.  Reliable in vitro studies require appropriate ovarian cancer cell lines.

Authors:  Francis Jacob; Sheri Nixdorf; Neville F Hacker; Viola A Heinzelmann-Schwarz
Journal:  J Ovarian Res       Date:  2014-06-07       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.